Taiko Pharmaceutical Co., Ltd. (4574)
JPX JPX Primary Summary
Taiko Pharmaceutical Co., Ltd. (4574) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Taiko Pharmaceutical Co., Ltd. ever had a stock split?
Taiko Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Takashi Shibata CEO | JPX Exchange | JP3442200006 ISIN |
| Japan Country | 220 Employees | - Last Dividend | 30 Mar 2020 Last Split | - IPO Date |
Overview
Taiko Pharmaceutical Co., Ltd. is a distinguished entity in the pharmaceutical industry, primarily engaged in the manufacturing and selling of over-the-counter (OTC) medicines. With its foundations laid in 1946, the company has forged a significant presence, not just within its home territory of Japan but also on an international scale. Headquartered in Osaka, Japan, Taiko Pharmaceutical Co., Ltd. embarked on its mission to cater to various health-related needs by offering a wide range of pharmaceutical products. Over the years, it has expanded its portfolio and market reach, demonstrating a strong commitment to enhancing health and well-being across the globe. The company’s dedication to innovation, combined with its rich legacy, has cemented its status as a trusted name in the pharmaceutical sector.
Products and Services
- OTC Medicines
Specializing in the treatment of gastrointestinal issues such as loose stools, diarrhea, vomiting, and symptoms of food and water poisoning, Taiko Pharmaceutical offers a comprehensive range of over-the-counter medicines. Catering to immediate relief and recovery, these products are designed with the consumer’s health and comfort in mind. In addition to gastrointestinal remedies, the company also provides solutions for toothache, thereby addressing a variety of common health concerns.
- Quasi-Drugs
Understanding the diverse needs of individuals, Taiko Pharmaceutical extends its offerings to include quasi-drugs, which play a pivotal role in regulating intestinal movements. These products are engineered to relieve stomach distention, loose stools, and constipation, ensuring overall digestive well-being. The quasi-drugs serve as a testament to the company’s innovative approach in developing versatile health care solutions.
- Infection Control Products
In response to the growing need for hygienic and safety measures, Taiko Pharmaceutical has ventured into the manufacturing and distribution of infection control products. These products are instrumental in preventing the spread of infections, safeguarding individuals and communities. Through this product line, the company demonstrates its capacity to adapt and contribute to global health security.
